A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies

• Unité de recherche: INNOSUISSE
• Numéro de projet: 26118.2 PFLS-LS

Description succincte (Allemand)

A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies

Description succincte (Anglais)

Résumé des résultats (Abstract) (Allemand)

Capitalizing on programmable cell fate regulation, we present a high-content screening platform measuring the differentiation capacity of pluripotent stem cells in a rapid, non-disruptive and inexpensive manner, enabling identification of high-quality stem cells for commercial applications.

Résumé des résultats (Abstract) (Anglais)